4.8 Article

RNase III nucleases from diverse kingdoms serve as antiviral effectors

期刊

NATURE
卷 547, 期 7661, 页码 114-+

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nature22990

关键词

-

资金

  1. Burroughs Wellcome Fund
  2. National Institute of Allergy and Infectious Diseases (NIAID) [R01A1074951]
  3. DIM Malinf, Conseil Regional d'Ile-de-France
  4. American Heart Association [15PRE24930012]
  5. National Science Foundation [MCB-1411836]
  6. NIAID [R21AI117882, R01AI110575]
  7. National Institute of General Medicine [F32 GM119235]

向作者/读者索取更多资源

In contrast to the DNA-based viruses in prokaryotes, the emergence of eukaryotes provided the necessary compartmentalization and membranous environment for RNA viruses to flourish, creating the need for an RNA-targeting antiviral system(1,2). Present day eukaryotes employ at least two main defence strategies that emerged as a result of this viral shift, namely antiviral RNA interference and the interferon system(2). Here we demonstrate that Drosha and related RNase III ribonucleases from all three domains of life also elicit a unique RNA-targeting antiviral activity. Systemic evolution of ligands by exponential enrichment of this class of proteins illustrates the recognition of unbranched RNA stem loops. Biochemical analyses reveal that, in this context, Drosha functions as an antiviral clamp, conferring steric hindrance on the RNA-dependent RNA polymerases of diverse positive-stranded RNA viruses. We present evidence for cytoplasmic translocation of RNase III nucleases in response to virus in diverse eukaryotes including plants, arthropods, fish, and mammals. These data implicate RNase III recognition of viral RNA as an antiviral defence that is independent of, and possibly predates, other known eukaryotic antiviral systems.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据